Storia in 2 fonti

Axsome pushes back generic entry for narcolepsy drug until 2040

Axsome has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040.

Raccontata da

endpoints.news

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo3 mesi fa

Axsome pushes back generic entry for narcolepsy drug until 2040

Axsome has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040.

originale

fiercepharma.com3 mesi fa

Axsome fends off generic competition to narcolepsy med Sunosi until 2040

With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its narcolepsy med Sunosi. | The company inked another settlement with a prospective generic maker,…

Leggi questa versione → originale

Timeline cronologica

mercoledì 3 giugno 2026·endpoints.news
Axsome pushes back generic entry for narcolepsy drug until 2040
Axsome has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040.
giovedì 4 giugno 2026·fiercepharma.com
Axsome fends off generic competition to narcolepsy med Sunosi until 2040
With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its narcolepsy med Sunosi. | The company inked another…